150 related articles for article (PubMed ID: 26211476)
41. Amyloid precursor protein regulates migration and metalloproteinase gene expression in prostate cancer cells.
Miyazaki T; Ikeda K; Horie-Inoue K; Inoue S
Biochem Biophys Res Commun; 2014 Sep; 452(3):828-33. PubMed ID: 25218471
[TBL] [Abstract][Full Text] [Related]
42. ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis.
Chiu KL; Kuo TT; Kuok QY; Lin YS; Hua CH; Lin CY; Su PY; Lai LC; Sher YP
Sci Rep; 2015 Nov; 5():16426. PubMed ID: 26553452
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.
Nishikawa R; Goto Y; Kurozumi A; Matsushita R; Enokida H; Kojima S; Naya Y; Nakagawa M; Ichikawa T; Seki N
Int J Urol; 2015 Sep; 22(9):867-77. PubMed ID: 26059417
[TBL] [Abstract][Full Text] [Related]
44. Involvement of the A disintegrin and metalloproteinase 9 in oral cancer cell invasion.
Buranaphatthana W; Wu S; Makeudom A; Sastraruji T; Supanchart C; Krisanaprakornkit S
Eur J Oral Sci; 2021 Jun; 129(3):e12775. PubMed ID: 33786875
[TBL] [Abstract][Full Text] [Related]
45. Licochalcone A inhibits the invasive potential of human glioma cells by targeting the MEK/ERK and ADAM9 signaling pathways.
Huang CF; Yang SF; Chiou HL; Hsu WH; Hsu JC; Liu CJ; Hsieh YH
Food Funct; 2018 Dec; 9(12):6196-6204. PubMed ID: 30465574
[TBL] [Abstract][Full Text] [Related]
46. Metalloprotease-disintegrin ADAM 12 binds to the SH3 domain of Src and activates Src tyrosine kinase in C2C12 cells.
Kang Q; Cao Y; Zolkiewska A
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):883-92. PubMed ID: 11104699
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of airway smooth muscle adhesion and migration by the disintegrin domain of ADAM-15.
Lu D; Xie S; Sukkar MB; Lu X; Scully MF; Chung KF
Am J Respir Cell Mol Biol; 2007 Oct; 37(4):494-500. PubMed ID: 17575078
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer.
Fu X; Zhang W; Su Y; Lu L; Wang D; Wang H
Prostate; 2016 May; 76(6):543-51. PubMed ID: 26771762
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
[TBL] [Abstract][Full Text] [Related]
50. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling.
Kwon GT; Cho HJ; Chung WY; Park KK; Moon A; Park JH
J Nutr Biochem; 2009 Sep; 20(9):663-76. PubMed ID: 18824345
[TBL] [Abstract][Full Text] [Related]
51. Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells.
Fu YM; Yu ZX; Li YQ; Ge X; Sanchez PJ; Fu X; Meadows GG
Nutr Cancer; 2003; 45(1):60-73. PubMed ID: 12791506
[TBL] [Abstract][Full Text] [Related]
52. Maslinic acid inhibits the metastatic capacity of DU145 human prostate cancer cells: possible mediation via hypoxia-inducible factor-1α signalling.
Park SY; Nho CW; Kwon DY; Kang YH; Lee KW; Park JH
Br J Nutr; 2013 Jan; 109(2):210-22. PubMed ID: 22716951
[TBL] [Abstract][Full Text] [Related]
53. Integrin binding characteristics of the disintegrin-like domain of ADAM-15.
Lu D; Chung KF; Xia M; Lu X; Scully M; Kakkar V
Thromb Haemost; 2006 Nov; 96(5):642-51. PubMed ID: 17080222
[TBL] [Abstract][Full Text] [Related]
54. Schwann Cells Increase Prostate and Pancreatic Tumor Cell Invasion Using Laminin Binding A6 Integrin.
Sroka IC; Chopra H; Das L; Gard JM; Nagle RB; Cress AE
J Cell Biochem; 2016 Feb; 117(2):491-9. PubMed ID: 26239765
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells.
Wu J; Ji A; Wang X; Zhu Y; Yu Y; Lin Y; Liu Y; Li S; Liang Z; Xu X; Zheng X; Xie L
J Transl Med; 2015 Sep; 13():289. PubMed ID: 26337460
[TBL] [Abstract][Full Text] [Related]
56. RhoB enhances migration and MMP1 expression of prostate cancer DU145.
Yoneda M; Hirokawa YS; Ohashi A; Uchida K; Kami D; Watanabe M; Yokoi T; Shiraishi T; Wakusawa S
Exp Mol Pathol; 2010 Feb; 88(1):90-5. PubMed ID: 19782069
[TBL] [Abstract][Full Text] [Related]
57. The role of zinc transporter ZIP4 in prostate carcinoma.
Chen QG; Zhang Z; Yang Q; Shan GY; Yu XY; Kong CZ
Urol Oncol; 2012; 30(6):906-11. PubMed ID: 21803616
[TBL] [Abstract][Full Text] [Related]
58. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
[TBL] [Abstract][Full Text] [Related]
59. RNAi-mediated ADAM9 gene silencing inhibits metastasis of adenoid cystic carcinoma cells.
Xu Q; Liu X; Cai Y; Yu Y; Chen W
Tumour Biol; 2010 Jun; 31(3):217-24. PubMed ID: 20422344
[TBL] [Abstract][Full Text] [Related]
60. An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases.
Chou CW; Huang YK; Kuo TT; Liu JP; Sher YP
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
